The business world was roiled earlier this year when a finance worker in Hong Kong was duped into handing over $25.6 million (200 million Hong Kong Dollars) after he joined a video call that…
Continue Reading
Tasked with reducing healthcare costs while improving patient outcomes and experience, many health insurance providers are mobilizing an array of add-on solutions — each one focused on filling a gap or addressing a specific…
Continue Reading
For years, I’ve watched promising medical technologies languish in labs, never reaching the patients who desperately need them. The culprit? Not overzealous regulators, but our antiquated approach to innovation. It’s time we stop pointing…
Continue Reading
Every second, someone somewhere in the United States takes a devastating fall, contributing to a massive $50 billion annual healthcare burden, a figure set to double by 2030 as the baby boomer population ages….
Continue Reading
You’ve heard the saying before, time and time again: sleep occupies nearly a third of our lives. From memory formation, concentration to overall wellness, the power of how we spend that 30 percent of…
Continue Reading
Home blood glucose monitoring was first introduced in 1980. While there were initially hurdles to overcome related to accuracy and cost, a consistent hurdle since that time has been efficient data sharing between patients…
Continue Reading
The popular Apple AirPods Pro 2 earbuds will soon function as hearing aids for people with self-perceived mild to moderate hearing loss. The Food and Drug Administration (FDA) announced on Thursday its authorization of…
Continue Reading
Some of the most challenging yet most important processes for digital health startups to navigate are those related to reimbursement and coding.
“People think, ‘Oh, I’ve got a code. I’m great. I can just go…
Continue Reading
The medical technology investment space is a pretty small ecosystem, according to medtech venture capitalist Maria Berkman.
“The number of venture funds that exclusively focus on medtech is relatively limited. There are probably less than…
Continue Reading
“The bottom line is that AI regulation is really about transparency. We don’t know everything.”
Those words were spoken by Luke Ralston — who has been a biomedical engineer and scientific reviewer at the FDA…
Continue Reading
